CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioglan Pharma PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioglan Pharma PLC
40A Wilbury Way
Phone: +44 1462633286p:+44 1462633286 Hitchin, Hertfordshire, ENG  SG4 0AP  United Kingdom Fax: +44 1462451400f:+44 1462451400
This company is no longer actively traded on any major stock exchange.
Business Summary
Bioglan Pharma PLC is a pharmaceutical company engaged in sales, manufacturing and research and development in the United Kingdom and the European Union, as well as sales and marketing in the United States. The Company's primary therapeutic focus is on dermatology and the majority of its product sales arise in this area; the Company's other focus areas are generics, pain control and drug delivery. The Company's product portfolio is predominantly in prescription pharmaceuticals. Bioglan Pharma PLC is the holding company of the Bioglan Group, and is responsible for Group strategy, corporate communication, human resources, public relations, investor relations, mergers and acquisitions, and financial and legal aspects. Bioglan Laboratories Ltd. is responsible for United Kingdom sales and marketing, and contract manufacturing services for the pharmaceutical, veterinary and healthcare industries, including the manufacture of products classed as medical devices.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
7/31/20011/31/2001-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer TerrySadler
Secretary, Corporate Affairs Director, Director SueKeast 1/1/1998
Scientific Director, Director Dr RupertMason

General Information
Number of Employees: 567 (As of 1/31/2001)
Outstanding Shares: 93,640,000 (As of 7/31/2001)
Shareholders: 2,922
Stock Exchange: LON
Fax Number: +44 1462451400


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023